Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

CardioMEMS brings in $22.6mm through its Series D venture round

Executive Summary

CardioMEMS (developing wireless medical pressure sensors for abdominal aortic aneurysms and heart failure) has raised $22.6mm through the sale of Series D preferred stock. Arcapita Ventures led the financing and was joined by other new investor Easton Capital Partners as well as current backers Boston Millennia Partners, Foundation Medical Partners, Medtronic, and J&J Development Corp. The company will use the proceeds to expand its technologies into the hypertension and cardiac surgery markets.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Implantable Devices
    • Monitoring Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies